Of the estimated five million patients in the U.S. diagnosed with heart failure annually, nearly half will have heart failure with preserved ejection fraction (HFpEF) and at the forefront of HFpEF research are Feinberg investigators.
Intensive treatment for patients with Crohn’s disease showed no safety differences compared to the current standard of care.
A team of investigators have discovered a novel genomic variant that may help clinicians predict which patients will experience cardiotoxicity from a widely used chemotherapy drug, according to a Northwestern Medicine study.
Electric shocks delivered by subcutaneous defibrillators are equally effective compared to shocks delivered by conventional transvenous defibrillators, according to a recent study.
Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to a recent clinical trial.
Northwestern scientists and clinicians demonstrated their continued commitment to advancing knowledge and therapies for amyotrophic lateral sclerosis during the 11th annual Les Turner Symposium on ALS.
A new drug improved management of ulcerative colitis, according to a study published in NEJM.
Women with early, nonviable pregnancies of unknown location who were given an active management strategy had more successful pregnancy resolutions than those given an expectant management strategy, according to a randomized clinical trial published in JAMA.
A colonoscopy maneuver to better detect polyps in the right colon is often poorly preformed in practice, according to a Northwestern Medicine study.
Four Northwestern Medicine hospitals have been recognized by U.S. News & World Report in its 2020-21 Best Hospitals rankings, with Northwestern Memorial Hospital named among the top 10 hospitals in the U.S.